glp-1 microdosing benefits Microdosing, Brain Health & Alzheimer's Prevention Should you microdose GLP-1 drugs

PLR-FOLF-00001-2 Rev

The peptide is one of two skin remodeling substances that may be able to downregulate the expression of metastatic genes

It remains to be further investigated, whether it is possible to avoid blunting of the inhibitory action by other types of inhibitors, by their combination or by combination of the diverse therapeutic modalities to efficiently limit propagation of tumor cells

Neuropeptide signalling proteoforms derived from VGF, somatostatin (SST) and protachykinin-1 (TAC1) showed higher abundance in AD-resilient than AD-dementia brain, whereas signalling proteoforms of cholecystokinin (CCK) and chromogranin (CHG) A/B and multiple cytoskeletal molecules were enriched in frail vs control brain

Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations

Abstract Epilepsy affects over 50 million individuals worldwide